
|Poll|December 21, 2022
POLL: Which 2022 Psoriasis FDA Approval Were You Most Excited About?
Author(s)Dermatology Times Staff
Click here to answer this week's poll.
Advertisement
Which 2022 Psoriasis FDA Approval Were You Most Excited About?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Phase 2 Nemolizumab Trial Opens for CPUO
3
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
4
Transformative Advances This Year and Beyond
5


















